Clinical evidence suggests that the prevalence and prognosis of AF are associated with serum levels of inflammatory biomarkers, such as IL-6, C-reactive protein (CRP), TNF-α, and monocyte chemoattractant protein (MCP)−1 [21]. This evidence concerns the gene IL6 and atrial fibrillation.